Evidence map›Paper›PMID 36262284›Full record

ArticleOxidative medicine and cellular longevity2022

Glutamine Transporter SLC1A5 Regulates Ionizing Radiation-Derived Oxidative Damage and Ferroptosis.

Zhuhui Yuan, Tong Liu, Xiao Huo, Hao Wang, Junjie Wang, Lixiang Xue

Abstract read
In one paragraph

Article in Oxidative medicine and cellular longevity, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Mechanism of Ferroptosis and Its Role in Disease Development.International journal of biological sciences · 2025
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Regulation of mCell death discovery · 2023
    Review
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Zhuhui YuanDepartment of Radiation Oncology, Peking University Third Hospital Cancer Center, Peking University Third Hospital, Haidian District, 49 Huayuan North Road, Beijing, China.ORCID https://orcid.org/0000-0003-3660-1492
Tong LiuCenter of Basic Medical Research, Institute of Medical Innovation and Research, Peking University Third Hospital Cancer Center, Peking University Third Hospital, Haidian District, 49 Huayuan North Road, Beijing 100191, China.
Xiao HuoCenter of Basic Medical Research, Institute of Medical Innovation and Research, Peking University Third Hospital Cancer Center, Peking University Third Hospital, Haidian District, 49 Huayuan North Road, Beijing 100191, China.
Hao WangDepartment of Radiation Oncology, Peking University Third Hospital Cancer Center, Peking University Third Hospital, Haidian District, 49 Huayuan North Road, Beijing, China.
Junjie WangDepartment of Radiation Oncology, Peking University Third Hospital Cancer Center, Peking University Third Hospital, Haidian District, 49 Huayuan North Road, Beijing, China.ORCID https://orcid.org/0000-0002-1388-076X
Lixiang XueCenter of Basic Medical Research, Institute of Medical Innovation and Research, Peking University Third Hospital Cancer Center, Peking University Third Hospital, Haidian District, 49 Huayuan North Road, Beijing 100191, China.ORCID https://orcid.org/0000-0003-1507-7193

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ionizing radiation-derived oxidative stress and ferroptosis are one of the most important biological effects on destroying the liver tumor, whereas radioresistance of liver tumor remains a leading cause of radiotherapy (RT) failure mainly because of the protective antiferroptosis, in which oxidative stress and subsequent lipid peroxidation are the key initiators. Thus, it is of great importance to overcome ferroptosis resistance to improve the therapeutic efficacy of RT in liver tumor patients. Irradiation-resistant HepG2 cells (HepG2-IRR) were established by long-term exposure to X-ray (2 to 8 Gy), and targeted metabolomics analysis revealed an obvious increase in intracellular amino acids in HepG2-IRR cells upon ferroptosis stress. Among these amino acids with obvious changes, N-acetylglutamine, a derivative of glutamine, is essential for the redox homeostasis and progression of tumor cells. Interestingly, the treatment of glutamine starvation could promote the ferroptosis effect significantly, whereas glutamine supplementation reversed the ferroptosis effect completely. Consistent with the changes in amino acids pattern, the glutamine transporter SLC1A5 was verified in liver tumor samples from TCGA training and validation cohorts as an independent prognostic amino acid-ferroptosis gene (AFG). A risk score for screening prognosis based on the SLC1A5, SLC7A11, ASNS, and TXNRD1 demonstrated that a high-risk score was correlated with poor survival.

Indexed as

FerroptosisLiver NeoplasmsAmino Acid Transport System ASCGlutamineHumansMinor Histocompatibility AntigensOxidative StressRadiation, IonizingAmino Acid Transport System ASCGlutamineMinor Histocompatibility AntigensSLC1A5 protein, human

Identifiers

PMID36262284
PMCPMC9576409

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.